Social Media for Colorectal Cancer Screening

NCT ID: NCT04296630

Last Updated: 2024-11-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Clinical Phase

NA

Total Enrollment

56000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-25

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Using social media for health promotion is an innovative and emerging approach but remains relatively unexplored in cancer screening. Uptake of colorectal cancer (CRC) screening remains low and standard methods of reaching out are expensive with limited impact. The objective of this study is to conduct a cluster randomized controlled trial (RCT) to test the effectiveness of social media messages for CRC screening on screening intention (primary outcome). The results of this trial will be of interest to Ontario Health and are likely to be taken up by other screening programs looking for innovative and novel ways to increase screening participation. The study results will be easily translatable identifying the most compelling CRC screening messages while the approach can easily be translated to other cancer disease sites with screening programs.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators will conduct a cluster randomized controlled trial (RCT) in Facebook users (aged 50+) in Ontario. Randomization will be done at the level of the forward sortation area (FSA) - the first three characters of the postal code. All FSAs in Ontario will be randomized to one of six study arms - users assigned to each arm will receive one of the social media messages or no message (control). If users click on the message, a webpage with further information on screening will appear and participants will be asked to indicate intention to get screened for CRC. The primary outcome will be intention to screen and secondary outcomes will include other engagement metrics such as reach, cost-per-click, click-through rates, number of likes, number of impressions, and post comments.

This study will inform the feasibility of using social media for CRC screening and identify the most compelling CRC screening messages for the screen-eligible population.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Cancer Cancer Screening

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Pragmatic cluster randomized controlled trial
Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Message #1

This arm will receive one of five social media messages that is preferred by our target population through focus groups that are being conducted as part of a previous study.

Group Type ACTIVE_COMPARATOR

Social media message #1

Intervention Type OTHER

Social media message promoting colorectal cancer screening

Message #2

This arm will receive the second social media message that is preferred by our target population as identified from our previous focus group study.

Group Type ACTIVE_COMPARATOR

Social media message #2

Intervention Type OTHER

A different social media message promoting colorectal cancer screening

Message #3

This arm will receive the third social media message that is preferred by our target population as identified from our previous focus group study.

Group Type ACTIVE_COMPARATOR

Social media message #3

Intervention Type OTHER

A different social media message promoting colorectal cancer screening

Arm #4

This arm will receive the fourth social media message that is preferred by our target population as identified from our previous focus group study.

Group Type ACTIVE_COMPARATOR

Social Media Message #4

Intervention Type OTHER

A different social media message promoting colorectal cancer screening.

Tailored Arm

This arm will receive social media messages that will be tailored by sex.

Group Type ACTIVE_COMPARATOR

Tailored Social Media Message

Intervention Type OTHER

Tailored social media messages promoting colorectal cancer screening.

Control Arm

This arm will not receive any intervention.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Social media message #1

Social media message promoting colorectal cancer screening

Intervention Type OTHER

Social media message #2

A different social media message promoting colorectal cancer screening

Intervention Type OTHER

Social media message #3

A different social media message promoting colorectal cancer screening

Intervention Type OTHER

Social Media Message #4

A different social media message promoting colorectal cancer screening.

Intervention Type OTHER

Tailored Social Media Message

Tailored social media messages promoting colorectal cancer screening.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Facebook users in Ontario who are between 55-64 years of age
Minimum Eligible Age

55 Years

Maximum Eligible Age

64 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

Sponsor Role collaborator

Unity Health Toronto

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nancy N. Baxter, MD, FRCSC, FACS, PhD

Role: PRINCIPAL_INVESTIGATOR

Unity Health Toronto

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Unity Health Toronto

Toronto, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20-005

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Colorectal Cancer Screening Outreach
NCT07345676 NOT_YET_RECRUITING NA